Finance

Lists
MRCK34:BVMF
Merck BDR
R$ ८३.३९
०.००%
(०.००) 1D
जुलाई २४, १६:५६:०० GMT-३  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for MRCK34...
Open
R$ ८३.७२
High
R$ ८३.७२
Low
R$ ८२.९१
Mkt. cap
३.२४ खरब
Avg. vol.
२.१९ हजार
Volume
३.९७ हजार
52-wk high
R$ ८४.८१
52-wk low
R$ ५१.०६
Shares outstanding
२.४७ अरब
No. of employees
७४ हजार
Open
R$ ८३.७२
High
R$ ८३.७२
Low
R$ ८२.९१
Mkt. cap
३.२४ खरब
Avg. vol.
२.१९ हजार
Volume
३.९७ हजार
52-wk high
R$ ८४.८१
52-wk low
R$ ५१.०६
Shares outstanding
२.४७ अरब
No. of employees
७४ हजार
News stories
From sources across the web
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck BDR
CEORobert M Davis
Employees७४ हजार
Founded१८९१ जनवरी १
Headquarters-
Sector-
Websitemerck.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
१५.८१ अरब
१७.२८ अरब
१६.४० अरब
१६.२९ अरब
Cost of goods sold
३.३९ अरब
३.७४ अरब
४.३० अरब
३.८८ अरब
Cost of revenue
३.३९ अरब
३.७४ अरब
४.३० अरब
३.८८ अरब
Research and development expenses
४.०० अरब
४.०० अरब
४.०० अरब
३.५६ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.५० अरब
२.४८ अरब
२.७३ अरब
२.५७ अरब
Operating expense
६.४९ अरब
६.४८ अरब
६.७३ अरब
६.१२ अरब
Total operating expenses
९.८८ अरब
१०.२३ अरब
११.०२ अरब
१०.०० अरब
Operating income
५.९२ अरब
७.०५ अरब
५.३८ अरब
६.२९ अरब
Other non operating income
६.९० करोड
-
४.१० करोड
४.२० करोड
EBT including unusual items
५.०० अरब
६.७४ अरब
३.४२ अरब
-३.५३ अरब
EBT excluding unusual items
५.६८ अरब
६.७६ अरब
४.९८ अरब
५.८५ अरब
Income tax expense
५७.१० करोड
९५.८० करोड
४५.८० करोड
७०.९० करोड
Effective tax rate
११.४२%
१४.२०%
१३.३९%
-२०.०६%
Other operating expenses
-
-
-
-
Net income
४.४३ अरब
५.७८ अरब
२.९६ अरब
-४.२४ अरब
Net profit margin
२८.०१%
३३.४९%
१८.०७%
-२६.०३%
Earnings per share
२.१३
२.५८
२.०४
-१.२८
Interest and investment income
६.९० करोड
९.६० करोड
६.९० करोड
३.५० करोड
Interest expense
-३०.५० करोड
-३२.७० करोड
-४१.१० करोड
-४७.९० करोड
Net interest expenses
-२३.६० करोड
-२३.१० करोड
-३४.२० करोड
-४४.४० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
६.९९ अरब
८.१५ अरब
६.७९ अरब
७.६९ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer